Small and Large Bowel
Overview
Evidence-driven progress in bowel health management.
Probiotics After Rifaximin May Reduce Relapse in IBS-D: JGH | August 2026
Introduction: Rifaximin can improve symptoms in diarrhoea-predominant irritable bowel syndrome (IBS-D), but relapse after treatment remains common. Because rifaximin alters the intestinal microbial environment, post-treatment microbiome modulation may help sustain response. This multicenter randomised trial...
Vancomycin Taper vs Fidaxomicin for Recurrent C. difficile Infection (OpTION Trial): NEJM Evidence | August 2026
Introduction: Recurrent Clostridioides difficile infection (CDI) remains a major clinical challenge, with recurrence occurring in up to one-third of patients after initial treatment. Although both vancomycin taper-and-pulse (VAN-TP) and fidaxomicin are recommended treatment options, high-quality...
DPP-4 Inhibition targeting the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026
Introduction: Increasing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This preclinical study investigated whether sitagliptin, a widely used DPP-4 inhibitor,...
Adjuvant Aspirin in Colorectal Cancer: The Lancet Gastroenterology & Hepatology | July 2026
Introduction: Although aspirin has long been investigated as adjuvant therapy for colorectal cancer (CRC), the overall ASCOLT trial showed no improvement in disease-free survival (DFS). This translational analysis evaluated whether specific molecular biomarkers could identify...
Anal High-Grade Squamous Intraepithelial Lesions (HSIL): BJS | March 2026
Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...
Post-Infection DGBI (PI-DGBI): Gut | July 2026
Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...
FMT in IBS: Gastroenterology | July 2026
Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...
Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026
Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...
DPP-4 Inhibition Targets the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026
Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...
Bedside Ultrasound Outperforms Abdominal X-Ray in Neonatal Necrotizing Enterocolitis: Frontiers in Pediatrics | July 2026
Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...
Common Drugs and Clostridioides difficile Infection: Gut | July 2026
Introduction: Antibiotic exposure is the best-established risk factor for Clostridioides difficile infection (CDI). However, the contribution of many commonly prescribed non-antibiotic medications has remained uncertain. This large Swedish population-based study evaluated the association between a...
Seated Anorectal Manometry Better Predicts Balloon Expulsion Success: AJG |June 2026
Dyssynergic defecation is commonly evaluated using anorectal manometry, traditionally performed in the left lateral decubitus position. However, defecation normally occurs in the seated position, raising questions about whether conventional testing accurately reflects real-world anorectal function....
DOTATATE PET in Poorly Differentiated Extrapulmonary NEC: JNM | June 2026
Somatostatin receptor (SSTR) imaging with ⁶⁸Ga-DOTATATE PET is a cornerstone for well-differentiated neuroendocrine tumors, but its role in poorly differentiated neuroendocrine carcinoma (NEC) has remained uncertain. Previous retrospective studies suggested that up to 40% of...
F. prausnitzii Counters CRC Progression : Gastroenterology | Jun 2026
Introduction: The gut microbiome plays a central role in colorectal cancer (CRC) development, influencing inflammation, metabolism, immune responses, and tumor behavior. While several microbial species have been implicated in CRC, the mechanisms through which beneficial...
Retatrutide in Type 2 Diabetes: Triple Agonist Delivers Powerful HbA1c and Weight Reduction: The Lancet | June 2026
Retatrutide is a once-weekly injectable triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors. TRANSCEND-T2D-1 evaluated retatrutide as monotherapy in adults with type 2 diabetes inadequately controlled with diet and exercise alone. The study...
MLCK1 Targeting Separates ICI Colitis from Antitumor Immunity : Gut | May 2026
Introduction Immune Checkpoint Inhibitors have transformed cancer treatment across multiple malignancies, but immune-related adverse events remain major limitations to durable therapy. Among these toxicities, Immune Checkpoint Inhibitor Colitis is particularly important because it frequently necessitates...
Gut Microbiota-Driven NETosis Promotes Endometriosis : Gut | May 2026
Introduction Endometriosis is a chronic inflammatory gynecological disease characterized by ectopic implantation of endometrial tissue and associated with pelvic pain, infertility and impaired quality of life. Although immune dysregulation and gut microbiota alterations have both...
High-Quality Colonoscopic Surveillance Reveals Distinct Neoplasia Patterns in Lynch Syndrome : Gut | May 2026
Introduction Lynch Syndrome remains the most common inherited colorectal cancer predisposition syndrome and is associated with markedly elevated lifetime risk of Colorectal Cancer. High-quality colonoscopic surveillance is central to cancer prevention and early detection in...
Gut–Testis Axis and Male Reproductive Health : Int J Mol Sci | May 2026
Introduction Emerging evidence suggests that the gut microbiome may play a central regulatory role in male reproductive physiology through a proposed “gut–testis axis.” This concept integrates microbial metabolism, systemic inflammation, endocrine signalling and immune regulation...
Gut Microbiota Diet Index Linked to Lower Mortality and Slower Biological Aging : J Nutr Health Aging | Jun 2026
Introduction The intestinal microbiome has emerged as a major regulator of metabolic health, inflammation and healthy aging. Dietary patterns strongly influence microbial diversity and metabolite production, with fiber-rich and plant-based diets generally promoting beneficial microbial...
Plant-Based Hospital Menus Maintain Nutritional Adequacy : Frontline Gastroenterol | May 2026
Introduction Healthcare systems are increasingly recognizing the environmental impact of hospital food services, particularly the high carbon footprint associated with meat-heavy diets. At the same time, maintaining adequate nutritional quality for hospitalized patients remains essential,...
Barriers to Prescription Therapy Persist in Chronic Idiopathic Constipation Care : Gastro Hep Advances | May 2026
Introduction Chronic idiopathic constipation (CIC) is one of the most common disorders of gut–brain interaction and is associated with substantial impairment in quality of life, healthcare utilization and economic burden. Although multiple effective prescription therapies...
Serrated Polyposis Syndrome Requires Improved Detection and Personalized Surveillance : Endoscopy | May 2026
Introduction Serrated polyposis syndrome (SPS) is now recognized as the most common colorectal polyposis syndrome and an important precursor condition for colorectal cancer (CRC). The syndrome is characterized by multiple serrated colorectal lesions, including sessile...
Persistent Diet–Microbiome–Epithelial Abnormalities Continue During Crohn’s Disease Remission : Gastroenterology | May 2026
Introduction Modern biologic therapies have significantly improved remission rates in Crohn’s disease (CD), primarily through suppression of mucosal immune activation. However, despite clinical and endoscopic remission, many patients continue to experience recurrent disease flares, suggesting...
Seronegative Enteropathies: FG | May 2026
Introduction Seronegative enteropathies (SNEs) represent a challenging group of disorders characterised by villous atrophy with negative coeliac serology. They include both seronegative coeliac disease (SNCD) and a broad spectrum of non-coeliac enteropathies such as infections,...
Rome V Anorectal Disorders: Gastroenterology | May 2026
The Rome V Anorectal Disorders chapter introduces several important revisions that substantially modernize the diagnostic and therapeutic approach to anorectal disorders within the disorders of gut–brain interaction (DGBI) framework. The chapter integrates symptom-based diagnosis with...
Rome V Bowel Disorders: Gastroenterology | May 2026
The Rome V Bowel Disorders chapter is one of the most clinically relevant revisions in Rome V because it substantially updates the diagnostic framework for disorders of gut–brain interaction (DGBI) involving bowel symptoms. The major...
Rome V Process: Gastroenterology | May 2026
The Rome V process represents the most rigorous methodological evolution in the history of the Rome Foundation and marks a major conceptual maturation in how disorders of gut–brain interaction (DGBI) are defined, classified, and managed....
Rome V Pediatric Lower DGBI: Gastroenterology | May 2026
Rome V reframes pediatric lower gastrointestinal disorders of gut–brain interaction (DGBI) around symptom clusters and anatomic domains rather than age-based groupings, a clinically important shift that better reflects how these disorders present in practice across...
IBD with IBS-Like Symptoms (Rome Foundation & IOIBD Joint Consensus): Gastroenterology | May 2026
Introduction A significant number of patients with inflammatory bowel disease in remission continue to report symptoms such as abdominal pain, bloating, and altered bowel habits. These symptoms often mimic irritable bowel syndrome, creating confusion in...
Gastrointestinal Involvement in Scleroderma: Gastroenterology | May 2026
Summary Systemic sclerosis (SSc), the systemic form of scleroderma, is a multisystem disorder characterised by fibrosis, vasculopathy, and immune dysregulation. Gastrointestinal involvement is extremely common, affecting up to 90% of patients, with the oesophagus being...
Antibiotic-Associated Diarrhea in ICU: JGH | March 2026
Introduction Antibiotic-associated diarrhea (AAD) is a frequent and clinically significant complication of antimicrobial therapy, particularly in critically ill patients. The pathogenesis primarily involves disruption of the gut microbiota, leading to impaired intestinal barrier function and...
Probiotics in IBS: JGH | March 2026
Introduction Irritable bowel syndrome is a highly prevalent functional gastrointestinal disorder with significant impact on quality of life and healthcare costs. Despite multiple therapeutic options, management remains challenging due to heterogeneity in symptoms and underlying...
Clostridioides difficile Infection: AMJ, March 2026
This review highlights that CDI management now requires both accurate diagnosis and a strategy to prevent recurrence. Diagnosis should not rely on a single test alone, because PCR is highly sensitive but may detect colonization,...
IBS Pharmacotherapy Safety: AMJ, March 2026
Introduction Choosing drug therapy for irritable bowel syndrome (IBS) requires balancing symptom benefit against treatment-related adverse effects. While clinicians often use the number needed to treat (NNT) to compare efficacy, the number needed to harm...
Global Dietary Patterns Influence Severity of IBS: CGH, March 2026
The role of habitual diet in the global epidemiology of irritable bowel syndrome (IBS) remains incompletely understood. In this large international analysis from the Rome Foundation Global Epidemiology Study, investigators evaluated whether regional dietary patterns...
Mucus Brushing and SIBO: Frontline Gastroenterology, March 2026
Introduction Upper small intestinal bacterial overgrowth (USIBO) is characterised by excessive bacterial colonisation in the duodenum or proximal jejunum, often leading to symptoms such as bloating, abdominal distension, and dyspepsia. Diagnosing USIBO remains challenging. Current...
Defecography Metrics in Chronic Constipation: Gastroenterology | March 2026
Introduction Chronic constipation is frequently evaluated using physiologic testing such as fluoroscopic defecography and high-resolution anorectal manometry to identify pelvic floor dysfunction and evacuation disorders. A recent study combined these techniques to define a synchronous...
Colonoscopy is the Best for CRC Screening: Gastroenterology | March 26
Introduction Colonoscopy has become the dominant colorectal cancer (CRC) screening test in the United States, credited with major reductions in CRC incidence and mortality through detection and polypectomy. Yet CRC screening uptake targets remain unmet,...
SAPP Defines “Gut Health”: Nature Reviews Gastro & Hepatol | Feb. 2026
“Gut health” is widely used by clinicians, researchers, industry, and the public—but until now lacked a unified, clinically usable definition. This ISAPP consensus statement convened an interdisciplinary expert panel to clarify what “gut health” should...
The Fiesole Consensus report
The Fiesole Consensus Report refers to an international set of guidelines and recommendations on the diagnosis, management, and prevention of diverticular disease. This consensus was developed by a group of 32 experts from 14 countries,...
Rome III vs Rome IV Criteria for IBS Diagnosis in Southeast Asia - J of JGH - Jan,26
The study published in the Journal of Gastroenterology and Hepatology (JGH) on January 26, titled "Rome III vs Rome IV Criteria for IBS Diagnosis in Southeast Asia," investigates how the adoption of the Rome IV...
Advances in Gut Microbiome and Metabolomics in IBD–Depression Comorbidity - J of JGH Jan,26
As of my training cutoff in October 2023, I cannot access or summarize the specific contents of the "Journal of Gastroenterology and Hepatology (JGH)" article dated January 26. However, based on the context provided, I...
Prevention of Acute Diverticulitis and DICA Score -Eur.J.Gastroenterol.Hepatol Jan 26
The prevention of acute diverticulitis (AD) based on the DICA (Diverticular Inflammation and Complication Assessment) score offers several key insights and takeaways for individualized management strategies. Below is a detailed summary: Introduction to the Problem...
A Gut Feeling
"A Gut Feeling" refers to the intuitive understanding of the profound impact the gut microbiota has on overall health, including gastrointestinal (GI), immune, endocrine, metabolic, and even neurological functions. This phrase metaphorically captures the growing...
Long-Term Venous Thromboembolism Risk in Microscopic Colitis
The long-term risk of venous thromboembolism (VTE) in individuals with microscopic colitis (MC) has been evaluated in a nationwide Swedish cohort study. Microscopic colitis is an inflammatory bowel disorder characterized by chronic watery diarrhea despite...
Efficacy and Safety of Linaclotide vs Plecanatide for Chronic Idiopathic Constipation
Linaclotide and plecanatide are both guanylate cyclase-C (GC-C) agonists approved for the treatment of chronic idiopathic constipation (CIC) in adults. While both drugs share a similar mechanism of action and are effective in treating CIC,...
Study Maps Genes Tied to Targets in Irritable Bowel Syndrome
Yes, the study you are referring to provides groundbreaking insights into the genetic underpinnings of Irritable Bowel Syndrome (IBS) and identifies potential therapeutic targets. This large genome-wide association study (GWAS) analyzed data from over 80,000...
The Impact of Emulsifiers on GI Health
The impact of dietary emulsifiers on gastrointestinal (GI) health has become a growing concern, particularly as the consumption of ultraprocessed foods—where these additives are commonly found—has risen globally. Emulsifiers are detergent-like substances added to food...
Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer
The study you are referring to evaluates the cost-effectiveness of different Lynch syndrome (LS) screening strategies in patients newly diagnosed with colorectal cancer (CRC). Lynch syndrome is a hereditary cancer syndrome that significantly increases the...
Peyer’s Patch B Cells Drive Celiac Disease Autoimmunity
Yes, Peyer’s patch B cells play a critical role in driving celiac disease autoimmunity. Here is a detailed explanation based on the context provided: Role of Peyer’s Patches in Celiac Disease: Peyer’s patches are specialized...
Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach
The approach to targeting Irritable Bowel Syndrome (IBS) through diet and mechanism-based therapies emphasizes addressing the underlying pathophysiological mechanisms rather than merely managing symptoms. IBS is recognized as a heterogeneous functional gastrointestinal disorder with multiple...
Diagnostic accuracy of biomarkers for irritable bowel syndrome: a systematic review and meta-analysis
The systematic review and meta-analysis you are inquiring about focuses on evaluating the diagnostic accuracy of emerging biomarkers for irritable bowel syndrome (IBS). IBS is a common gastrointestinal disorder that has traditionally been diagnosed based...
Editorial: Diverticulitis – A neglected disease despite its clinical burden
The editorial titled "Diverticulitis – A neglected disease despite its clinical burden" sheds light on diverticulitis as a significant yet underappreciated gastrointestinal condition that imposes a substantial burden on both patients and healthcare systems. Despite...
mt-sDNA is supior tool for CRC screening
Yes, multitarget stool DNA (mt-sDNA) is considered a superior tool for colorectal cancer (CRC) screening, especially for younger adults under 50, based on the findings of the study outlined in the context. Here's why mt-sDNA...
Why immunotherpay often fails in CRC
Colorectal cancer (CRC) is one of the most common types of cancer worldwide, and its treatment often involves surgery, chemotherapy, and radiation therapy. However, metastatic colorectal cancer (advanced-stage cancer that spreads to other parts of...
Salmonella Paratyphi A Vaccine
The study you are asking about focuses on the development and testing of a promising oral live attenuated vaccine, named CVD 1902, specifically designed to prevent Salmonella Paratyphi A infections. Here's a detailed summary of...
Diverticulitis
Diverticulitis is a medical condition characterized by the inflammation or infection of small, bulging pouches (diverticula) that can form in the lining of the digestive system, most commonly in the colon. It is a more...
Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis - NEJM Publication
The study on intravenous (IV) rehydration for severe acute malnutrition (SAM) with gastroenteritis was published in the New England Journal of Medicine (NEJM) and provides critical insights into the management of severely malnourished children with...
Genetic Risk Assessment and Testing for GI Cancers and Polyposis
Genetic risk assessment and testing for gastrointestinal (GI) cancers and polyposis syndromes are critical components of modern clinical practice. They aim to identify individuals and families at increased risk of developing hereditary cancer syndromes, enabling...
The Exclusion Diet Conundrum and IBS
The exclusion diet conundrum refers to the debate surrounding the effectiveness and validity of using food-specific IgG (FS-IgG) testing to guide dietary eliminations for managing irritable bowel syndrome (IBS). IBS is a chronic gastrointestinal condition...
Severe Diverticulitis Among Younger Americans
The rise in severe diverticulitis among younger Americans is a concerning trend that reflects significant shifts in the disease's epidemiology. Traditionally associated with older adults, diverticulitis is now increasingly affecting individuals under 50. A large-scale...
Long-Acting GLP-2 Analogue (Glepaglutide) and Short Bowel Syndrome
Glepaglutide is a long-acting GLP-2 (glucagon-like peptide-2) analogue designed to improve intestinal function and absorption in patients with short bowel syndrome (SBS). SBS is a condition characterized by the loss of significant portions of the...
Ileal Pouch Anal Anastomosis and Pouch Neoplasm
Ileal Pouch-Anal Anastomosis (IPAA): Ileal Pouch-Anal Anastomosis (IPAA) is a surgical procedure typically performed to restore bowel continuity after the removal of the colon and rectum. It is most commonly used in patients with ulcerative...
Ergosterol, visceral hypersensitivity and IBS
Ergosterol: Ergosterol is a naturally occurring sterol compound found in fungi, particularly in fungal cell membranes. Structurally, it is similar to cholesterol, which is found in animal cells. Ergosterol is commonly present in foods derived...
FIREFLI ingestible capsule enable luminance-based diagnosis of acute mesenteric ischemia,
Yes, the FIREFLI ingestible capsule is a groundbreaking device that enables luminance-based diagnosis of acute mesenteric ischemia (AMI). AMI is a severe condition caused by insufficient blood flow to the intestines, often leading to tissue...
Hyperbaric oxygen therapy for radiation enteritis
Hyperbaric oxygen therapy (HBOT) has emerged as a promising treatment for radiation enteritis (RE), a debilitating complication affecting up to 80% of patients undergoing pelvic radiotherapy, with 5–20% developing chronic severe RE. A systematic review...
Colorectal polyps in patients with limited life expectancy - BSG View
The British Society of Gastroenterology (BSG) provides guidance for managing colorectal polyps in patients with a life expectancy of less than 10 years, focusing on balancing the risks and benefits of polypectomy versus conservative management....
Butyrate and Clostridioides difficile infection
Butyrate, a short-chain fatty acid produced by the fermentation of dietary fiber by gut microbiota, plays a critical role in maintaining intestinal health and has significant implications for Clostridioides difficile (C. difficile) infection. C. difficile...
Ferroptosis-related genes in small intestinal NETs
The study focused on identifying ferroptosis-related genes in small intestinal neuroendocrine neoplasms (SI-NENs) and their diagnostic and therapeutic potential. Ferroptosis, an iron-dependent cell death mechanism, was analyzed using bioinformatics and machine learning on RNA sequencing...
A value of D-dimer in acute arterial mesenteric ischemia
In acute arterial occlusive mesenteric ischemia (AOMI), baseline serum D-dimer levels hold significant prognostic value. The study found that elevated D-dimer levels were strongly associated with both short-term (30-day) and long-term (1-year) mortality. Non-survivors had...
IBS-Specific IgG ELISA-Based Elimination Diet in IBS
The IBS-specific IgG ELISA-based elimination diet is a personalized dietary intervention designed to address food sensitivities in individuals with irritable bowel syndrome (IBS). This approach leverages an IgG antibody assay to identify specific food triggers...
TEDDY Study - Dietary Supplements, reduces Celiac Disease Risk
The TEDDY study primarily investigated dietary factors, focusing on dietary fiber intake rather than supplements, in relation to celiac disease risk among genetically predisposed children. It followed 6,520 children with HLA-DQ2 or DQ8 haplotypes from...
Microbiome-Directed Therapy for Malnutrition
Microbiome-directed therapy for malnutrition represents a groundbreaking approach to addressing childhood undernutrition by targeting the gut microbiome, a critical determinant of health and growth outcomes. Traditional treatments, such as ready-to-use supplementary food (RUSF), primarily focus...
Imaging findings of IBS patients
Imaging studies have revealed several significant findings in patients with irritable bowel syndrome (IBS). These findings span both abdominal and brain imaging, shedding light on the structural and functional abnormalities associated with the condition. Below...
Microbiota and IBD-C
Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of IBS characterized by chronic constipation, abdominal discomfort, and altered bowel habits. The study you referenced explored the relationship between gut microbiota and IBS-C, uncovering critical insights...
Risk of IBD in IBS patients
Irritable bowel syndrome (IBS) is linked to an increased long-term risk of developing inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). A large study using UK Biobank data followed 447,631 participants...
Healthy Lifestyle and Bowel Disease Risk
The study conducted by researchers at the University of Oslo in collaboration with the Song Lab at Harvard T.H. Chan School of Public Health provides compelling evidence that adopting a healthier lifestyle after undergoing bowel...
ACTION Trial
The ACTION trial was a significant clinical study designed to evaluate the efficacy and safety of acupuncture in treating diarrhea-predominant irritable bowel syndrome (IBS-D). Below is a detailed summary of the trial: --- Background Global...
Five herbs and spices that could help improve digestion
Here are five herbs and spices that can help improve digestion, along with detailed explanations of their benefits: Peppermint Active Compound: Menthol. Benefits: Relaxes gut muscles, reducing bloating, gas, and abdominal pain. Calms inflammation and...
GI diseases, sleep disturbances, and the role of depression
The study you provided sheds significant light on the complex interplay between gastrointestinal (GI) diseases, sleep disturbances, and depression, highlighting both direct and indirect pathways through which these health concerns are interconnected. Below is a...
Alopecia Areata and immune-mediated GI) conditions
Alopecia areata (AA), an autoimmune disorder characterized by hair loss, has been found to be significantly associated with an increased risk of various gastrointestinal (GI) immune-mediated conditions, according to a comprehensive study that analyzed data...
Diagnostic accuracy of tTG level in Paediatric Celiac Disease
The diagnostic accuracy of tissue transglutaminase IgA (tTG-IgA) levels in pediatric celiac disease was assessed in a large North American study involving 4019 children under 18 years from 12 hospitals across Canada and the United...
CAMs and GI Disorders
Complementary and Alternative Medicine (CAM) is increasingly being recognized as a valuable adjunct in the management of gastrointestinal (GI) disorders, particularly as the prevalence of these conditions rises due to modern lifestyle factors such as...
Sarcopenia in Crohn's Disease
Sarcopenia in Crohn's Disease (CD), particularly in pediatric patients, is a significant clinical concern. Below is a detailed summary of its prevalence, prognostic value, clinical implications, and management considerations based on the study findings: Definition...
Proteome-Based Biopsy Scoring for Mucosal Remodeling in Celiac Disease
Proteome-Based Biopsy Scoring for Mucosal Remodeling in Celiac Disease refers to a novel approach that utilizes mass spectrometry–based proteomics to assess mucosal changes in the small intestine of individuals with celiac disease. This method provides...
Prediction Models for Early Celiac Disease in Genetically Susceptible Children
The study titled "Prediction Models for Early Celiac Disease in Genetically Susceptible Children" comes from the PreventCD project, which aimed to understand and predict the development of celiac disease in children at high genetic risk....
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
CD19 CAR T-cell therapy, a treatment traditionally used for certain types of B-cell malignancies, has shown promise in a case of severe, multidrug-resistant ulcerative colitis (UC). This novel approach led to drug-free remission and mucosal...
ARFID and IBD
Avoidant/restrictive food intake disorder (ARFID) and inflammatory bowel disease (IBD) share a complex relationship. ARFID is an eating disorder characterized by restrictive eating patterns often driven by anxiety, sensory sensitivity, or fear of adverse consequences,...
PLANET study
The PLANET study is a research initiative that is prospectively investigating the exposure to micro- and nanoplastics in pregnant women and their children. It is part of the growing body of research aimed at understanding...
PFAS, Pesticides and IBD
Per- and polyfluoroalkyl substances (PFAS) and agricultural pesticides are increasingly recognized as environmental factors that contribute to the risk of inflammatory bowel diseases (IBD), particularly Crohn's disease. Here’s a detailed breakdown of their roles and...
Obesity and response to IBD treatment
Obesity has been identified as a significant factor influencing the response to treatment in patients with inflammatory bowel disease (IBD). A large registry-based study from the Initiative on Crohn and Colitis evaluated 1,066 patients initiating...
Hypogonadism and Bone Health in IBD
Hypogonadism and Bone Health in IBD (Inflammatory Bowel Disease) Hypogonadism is a common complication in patients with IBD, and it has significant implications for bone health. The interplay of poor nutrition, chronic inflammation, and the...
Ultraprocessed Food and Premature Death
Ultraprocessed foods (UPFs) have been linked to higher rates of premature death, according to a global analysis conducted across eight countries. The study highlights a clear dose–response pattern: for every 10% increase in daily energy...
Obesity and Gut Microbiota
Obesity and gut microbiota are intricately linked, as the microbial composition and functions in the gut play a significant role in energy balance, metabolism, and fat storage. The gut microbiota refers to the trillions of...
DGBI and Carbohydrate intolerance
Disorders of Gut-Brain Interaction (DGBI) and Carbohydrate Intolerance: Overview of DGBI: Disorders of Gut-Brain Interaction (DGBI) encompass a group of conditions characterized by abnormal communication between the gut and the brain. These disorders include conditions...
Auto-Brewery Syndrome (ABS)
Auto-Brewery Syndrome (ABS), also referred to as gut fermentation syndrome, is a rare and likely underdiagnosed medical condition in which gut microbes (bacteria and/or yeast) ferment carbohydrates into ethanol (alcohol) within the gastrointestinal tract. This...
Extra bacterial Gut Ecosystem
The gut ecosystem is predominantly composed of bacteria, but emerging research highlights the importance of other microbial entities, such as fungi and bacteriophages, which play crucial roles in maintaining gut health and influencing disease outcomes....
Obefazimod (ABX464) in Ulcerative Colitis
Obefazimod, also known as ABX464, is a first-in-class small molecule with a novel mechanism of action specifically designed to treat moderate-to-severe ulcerative colitis (UC). Below is a detailed overview of its features, mechanism, clinical trials,...
Binge Eating Disorder (BED)
Binge Eating Disorder (BED) is a serious and common eating disorder characterized by recurrent episodes of consuming large quantities of food in a short period, often accompanied by feelings of loss of control, distress, and...
Auricular Vagus Nerve Stimulation in Constipation-Predominant IBS
Auricular vagus nerve stimulation (taVNS) has emerged as a promising non-invasive neuromodulation therapy for managing constipation-predominant irritable bowel syndrome (IBS-C). A randomized controlled trial has demonstrated that taVNS offers significant benefits across multiple dimensions of...
Intestinal Ultrasound–Defined Active IBD in Pregnancy and Adverse Obstetric Outcomes
The use of intestinal ultrasound (IUS) to monitor disease activity in pregnant women with inflammatory bowel disease (IBD) has been shown to have significant prognostic value in predicting adverse obstetric outcomes. The findings of the...
Habitual Dietary Patterns and Quality in Irritable Bowel Syndrome
The study on habitual dietary patterns and quality in Irritable Bowel Syndrome (IBS) highlights significant differences in the dietary habits and overall diet quality of IBS patients compared to matched population controls. Here are the...
FUT7 Enhances Regulatory T-Cell Homing and Immunosuppression in IBD
Yes, the research findings support the conclusion that FUT7 enhances regulatory T-cell (Treg) homing and immunosuppression in inflammatory bowel disease (IBD). Here's a detailed explanation based on the context provided: FUT7 and Its Role in...
The IntAct Trial: ICG Fluorescence Angiography in Rectal Cancer Surgery
The IntAct trial investigated the use of indocyanine green (ICG) fluorescence angiography as a tool to reduce anastomotic leaks during rectal cancer surgery. Anastomotic leaks, which occur when the surgical connection between two sections of...
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
The study you are referring to investigated the use of low-dose aspirin as a preventive strategy for recurrence in patients with localized colorectal cancer harboring alterations in the PI3K pathway. Below is a detailed summary...
Dietary nutrient patterns and the risk of IBS
The study investigated the relationship between dietary nutrient patterns and the risk of developing Irritable Bowel Syndrome (IBS) in a diverse Iranian population. Here are the detailed findings and insights: --- Study Overview Objective: To...
12-week low FODMAP diet and levels of GLP-1 in IBS
The study investigated the effects of a 12-week low FODMAP diet (LFD) on GLP-1 (glucagon-like peptide-1) levels in patients with moderate-to-severe irritable bowel syndrome (IBS). Here is a detailed breakdown of the findings and their...
Factors associated with symptom relief in patients with irritable bowel syndrome
The study identifies several demographic, lifestyle, psychological, and physiological factors associated with symptom relief in patients with irritable bowel syndrome (IBS). Here’s a detailed breakdown of the findings: --- 1. Demographic Factors Age: The average...
More topics
Exam Corner
Your hub for focused learning and smart preparation.
Artificial Intelligence
Transforming data into intelligent decisions.
Cirrhosis Liver
Precision insights for better liver outcomes.
Liver Transplantation
Advancing outcomes through surgical excellence.
Fatty Liver Disease
Promoting liver health through early insight and action.
Endoscopy
Clear vision for a healthier tomorrow.
Basic Sciences
Building the foundation of medical understanding.
HCC
Awareness saves lives. Early action matters.
IBD
Evidence-based care for chronic intestinal conditions.
Hepatitis
Evidence-based insights. Better liver health
Oncology
Transforming Oncology with Next-Gen Science
Gallbladder and Pancreas
Precision insights. Smarter healthcare.
Upper GI Tract
Supporting better digestion through informed care.”
GI Surgery
Advancing precision and outcomes in gastrointestinal care.
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.